Altrius Capital Management Inc Acquires 6,545 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Altrius Capital Management Inc boosted its stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 3.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 189,993 shares of the company's stock after buying an additional 6,545 shares during the quarter. Roche makes up about 1.9% of Altrius Capital Management Inc's holdings, making the stock its 21st biggest position. Altrius Capital Management Inc's holdings in Roche were worth $7,818,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of RHHBY. GAMMA Investing LLC boosted its holdings in Roche by 6,463.8% in the first quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock worth $21,759,000 after purchasing an additional 520,722 shares in the last quarter. Boston Common Asset Management LLC lifted its position in shares of Roche by 10.0% in the first quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock worth $13,369,000 after buying an additional 29,522 shares during the last quarter. Bard Financial Services Inc. boosted its stake in shares of Roche by 25.3% during the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after acquiring an additional 28,050 shares in the last quarter. Rhumbline Advisers increased its holdings in shares of Roche by 7.4% during the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock valued at $4,413,000 after acquiring an additional 7,374 shares during the last quarter. Finally, Riverbridge Partners LLC raised its stake in shares of Roche by 6.7% in the 1st quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock valued at $1,557,000 after acquiring an additional 2,381 shares in the last quarter.

Roche Stock Performance

Shares of OTCMKTS:RHHBY traded down $0.50 on Wednesday, hitting $40.29. 1,054,464 shares of the company were exchanged, compared to its average volume of 1,172,916. The company's 50 day moving average price is $39.83 and its two-hundred day moving average price is $39.24. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.20 and a current ratio of 1.48. Roche Holding AG has a one year low of $33.76 and a one year high of $44.31.

Wall Street Analysts Forecast Growth

RHHBY has been the subject of a number of research analyst reports. Hsbc Global Res lowered shares of Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. HSBC lowered Roche from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy".

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.